We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

11 hedge funds and large institutions have $2.13M invested in VIVEVE MED INC in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% less funds holding

Funds holding: 30 → 11 (-19)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

73% less capital invested

Capital invested by funds: $7.82M → $2.13M (-$5.68M)

86% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 22

Holders
11
Holders Change
-19
Holders Change %
-63.33%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
+$7.53M
2
Goldman Sachs
Goldman Sachs
New York
+$427K
3
FIA
FNY Investment Advisers
New York
+$291K
4
Victory Capital Management
Victory Capital Management
Texas
+$1.44K

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$2.5M
2
RI
RTW Investments
New York
-$1.7M
3
SCM
Stonepine Capital Management
Oregon
-$1.29M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$520K
5
MIH
Meitav Investment House
Israel
-$352K

VIVE Hedge Fund Activity: Q3 2019 in Review

11 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q3 2019, worth a combined $2.13M — down 73% from $7.82M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VIVE and 3 opened new positions — a net loss of 19 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was HighTower Advisors, adding an estimated $7.53M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $2.5M sold.

  • 11 institutional investors held VIVEVE MED INC (VIVE) as of Q3 2019, down from 30 in Q2 2019.
  • Funds reported $2.13M of VIVEVE MED INC stock for Q3 2019, down 73% quarter-over-quarter.
  • 3 funds opened new VIVEVE MED INC positions in Q3 2019 and 22 closed out, a net change of -19 holders.
  • The largest VIVEVE MED INC buyer in Q3 2019 was HighTower Advisors, an estimated $7.53M added.
  • The largest VIVEVE MED INC seller in Q3 2019 was Nantahala Capital Management, an estimated $2.5M sold.

Based on aggregated 13F filings for Q3 2019.